Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1795-2026Class II

B.R.A.H.M.S PlGF Plus KRYPTOR, Catalog Number: 859075N. in vitro diagnostic test for Placental Growth Factor

B.R.A.H.M.S GmbH / initiated 2026-03-12 / Open, Classified / root cause: labeling and UDI

Brahms GmbH began a recall of B.R.A.H.M.S PlGF Plus KRYPTOR, Catalog Number: 859075N. in vitro diagnostic test for Placental Growth Factor on . FDA classified it as Class II and gives the reason as "Customers have observed quality control values out of range at the lowest quality control level (QC Level 1) for the PIGF assay which require troubleshooting steps to resolve. If Quality Controls are not performed...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1795-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
B.R.A.H.M.S GmbH
Product
B.R.A.H.M.S PlGF Plus KRYPTOR, Catalog Number: 859075N. in vitro diagnostic test for Placental Growth Factor
Product code
QWH Prognostic Test For Development Or Progression Of Preeclampsia
Reason for recall
Customers have observed quality control values out of range at the lowest quality control level (QC Level 1) for the PIGF assay which require troubleshooting steps to resolve. If Quality Controls are not performed according to the Instructions for Use, the underestimation of QC1 may go undetected and could contribute to falsely elevated sFlt-1/PlGF ratio results. A falsely elevated sFlt-1/PlGF ratio may result in a higher-risk classification for progression to preeclampsia with severe features potentially leading to intensified clinical monitoring.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
On 2/27/2026, correction notices were sent to customers informing them: 1. Continue to perform Quality Control testing in accordance with the current Instructions for Use prior to reporting patient results. 2. If Quality Control results fall outside plus-minus 20% of target values follow the troubleshooting procedures described in the User Manual. 3. Forward this letter to those who need to be aware within your organization or to any organization to whom the potentially affected devices have been transferred. Keep this notification on file. For further questions, please contact the firm's customer service on 1-800-232-3342 or e-mail to: [email protected]
Quantity in commerce
5,254
Distribution
Worldwide distribution. US states: NC, TX, MN, UT, NY, FL, OH, IL, CT, CA, GA. Other countries: DE, AT, AL, AU, BG, BR, CA, CH, CZ, DK, ET, ES, FR, GB, GR, HK, HU, ID, IL, IT, KW, KZ, LT, MK, ML, MX, NL, NO, PA, PL, PT, RO, SE, SI, TH, TU, TW, UA, ZA
Product codes and lots
UDI: 04260157632196. Lot(Expiration): 59172(2026-11-23), 859075N(2026-11-23)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1795-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1795-2026Class IIOngoingVoluntary: Firm initiated